Ortho Studio Express

Ortho Studio Express appears to be a small, private U.S. corporate entity associated with orthodontics and healthcare investing rather than a drug-development biotech company. Publicly accessible sources indicate it is incorporated in Wisconsin and has been described by investment databases as a venture or corporate investor. The clearest identified activity is participation as a minority investor in uLab Systems' January 2020 Series D financing, which was tied to digital orthodontic aligner-planning software. No evidence was found of a therapeutic pipeline, clinical-stage assets, drug programs, or conventional pharma/biotech R&D operations. Based on available information, the entity is best characterized as an orthodontics-related corporate/investment vehicle with very limited public disclosure.